Are you Dr. Singh?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 68 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1025 Marsh St
Mankato, MN 56001Phone+1 507-625-4031Fax+1 507-385-2908
Summary
- Dr. Ripudamanjit Singh, MD is a cardiologist in Mankato, Minnesota. He is currently licensed to practice medicine in Minnesota, California, and North Dakota. He is affiliated with Mayo Clinic Health System in Waseca, Mayo Clinic Health System-Albert Lea and Austin, and Mayo Clinic Hospital - Rochester.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Interventional Cardiology, 2004 - 2005
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Cardiovascular Disease, 2000 - 2004
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1997 - 2000
- Government Medical College PatialaClass of 1990
Certifications & Licensure
- CA State Medical License 2005 - Present
- MN State Medical License 1999 - 2025
- IA State Medical License 1999 - 2005
- ND State Medical License 2005 - 2005
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- 21 citationsHigh-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19.Laura De Michieli, Olatunde Ola, Jonathan D. Knott, Ashok Akula, Ramila A. Mehta
Clinical Chemistry. 2021-04-16 - 41 citationsEndothelial-derived tissue factor pathway inhibitor regulates arterial thrombosis but is not required for development or hemostasisThomas A. White, Tucker F. Johnson, Natalia Zarzhevsky, Cindy W. Tom, Sinny Delacroix
Blood. 2010-09-09 - 22 citationsFrequency, etiology, treatment, and outcomes of drug-eluting stent thrombosis during one year of follow-up.Gurpreet S. Sandhu, Brendan Doyle, Ripudamanjit Singh, Malcolm R. Bell, John F. Bresnahan
The American Journal of Cardiology. 2007-02-15